Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD, PhD, Mihir Gandhi, MS, Mathias Worni, MD, Ricardo Pietrobon, MD, MPH, Thomas A. D'Amico, MD The Annals of Thoracic Surgery Volume 93, Issue 6, Pages 1807-1812 (June 2012) DOI: 10.1016/j.athoracsur.2012.03.018 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Flow diagram of patients included in systematic review and meta-analysis. The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Forest plot of overall survival of patients in randomized studies receiving induction chemotherapy versus induction chemoradiotherapy followed by resection. (CI = confidence interval; SE = standard error.) The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Forest plot of overall survival of patients in retrospective studies receiving induction chemotherapy versus induction chemoradiotherapy followed by resection. (CI = confidence interval; SE = standard error.) The Annals of Thoracic Surgery 2012 93, 1807-1812DOI: (10.1016/j.athoracsur.2012.03.018) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions